Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Prevnar 13
Pharma
SK defeats Pfizer in Korean patent feud
Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.
Fraiser Kansteiner
May 21, 2025 9:39am
Big Pharma reworks China strategy, and job cuts are part of it
Dec 22, 2023 8:22am
FDA signs off on Pfizer's Prevnar 20 to vaccinate infants
Apr 28, 2023 9:15am
FDA grants Pfizer's Prevnar 20 priority review for pediatric use
Jan 6, 2023 10:20am
Pfizer shows key data, setting up pediatric nod for Prevnar 20
Aug 12, 2022 10:50am
Merck's Prevnar rival snags key pediatric nod
Jun 22, 2022 6:45am
